Dihydroartemisinin induces apoptosis in human gastric cancer cell line BGC-823 through activation of JNK1/2 and p38 MAPK signaling pathways

References

• Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533–43.
   PubMed Web of Science ®Google Scholar
• Wang YH, Zhou ZB, Guo CA, et al. Role of mimic of manganese superoxide dismutase in proliferation and apoptosis of gastric carcinoma BGC-823 cells in vitro and in vivo. Int Immunopharmacol 2015;26:277–85.
   PubMed Web of Science ®Google Scholar
• Su CC, Chen JY, Din ZH, et al. 13-acetoxysarcocrassolide induces apoptosis on human gastric carcinoma cells through mitochondria-related apoptotic pathways: p38/JNK activation and PI3K/AKT suppression. Mar Drugs 2014;12:5295–315.
   PubMed Web of Science ®Google Scholar
• Wu C, Liu J, Pan X, et al. Design, synthesis and evaluation of the antibacterial enhancement activities of amino dihydroartemisinin derivatives. Molecules 2013;18:6866–82.
   PubMed Web of Science ®Google Scholar
• Flobinus A, Taudon N, Desbordes M, et al. Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives. J Antimicrob Chemother 2014;69:34–40.
   PubMed Web of Science ®Google Scholar
• Hou J, Wang D, Zhang R, Wang H. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin Cancer Res 2008;14:5519–30.
   PubMed Web of Science ®Google Scholar
• Wang SJ, Gao Y, Chen H, et al. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett 2010;293:99–108.
   PubMed Web of Science ®Google Scholar
• Singh NP, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 2001;70:49–56.
   PubMed Web of Science ®Google Scholar
• Nam W, Tak J, Ryu JK, et al. Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. Head Neck 2007;29:335–40.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Ge CM, Meng QH, et al. Dihydroartemisinin is an inhibitor of ovarian cancer cell growth. Acta Pharmacol Sin 2007;28:1045–56.
   PubMed Web of Science ®Google Scholar
• Mu D, Zhang W, Chu D, et al. The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells. Cancer Chemother Pharmacol 2008;61:639–45.
   PubMed Web of Science ®Google Scholar
• Lu YY, Chen TS, Qu JL, et al. Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells. J Biomed Sci 2009;16:16.
   PubMed Web of Science ®Google Scholar
• Zhou HJ, Zhang JL, Li A, et al. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro. Cancer Chemother Pharmacol 2010;66:21–9.
   PubMed Web of Science ®Google Scholar
• Hosoya K, Murahari S, Laio A, et al. Biological activity of dihydroartemisinin in canine osteosarcoma cell lines. Am J Vet Res 2008;69:519–26.
   PubMed Web of Science ®Google Scholar
• Jia LF, Song Q, Zhou CY, et al. Dihydroartemisinin as a putative STAT3 inhibitor, suppresses the growth of head and neck squamous cell carcinoma by targeting Jak2/STAT3 Signaling. PLoS One 2016;11:e0147157.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Momen A, Afroze T, Sadi AM, et al. Enhanced proliferation and altered calcium handling in RGS2-deficient vascular smooth muscle cells. J Recept Signal Transduct Res 2014;34:476–83.
   PubMed Web of Science ®Google Scholar
• Chua CW, Lee DT, Ling MT, et al. FTY720, a fungus metabolite, inhibits in vivo growth of androgen independent prostate cancer. Int J Cancer 2005;117:1039–48.
   PubMed Web of Science ®Google Scholar
• Cheng HB, Bo Y, Shen WX, et al. Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS. Naunyn Schmiedebergs Arch Pharmacol 2015;388:623–34.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Nagappan A, Park HS, et al. Flavonoids isolated from Citrus platymamma induce mitochondrial-dependent apoptosis in AGS cells by modulation of the PI3K/AKT and MAPK pathways. Oncol Rep 2015;34:1517–25.
   PubMed Web of Science ®Google Scholar
• Huang HL, Hsieh MJ, Ming-Hsien Chien MH, et al. Glabridin mediate caspases activation and induces apoptosis through JNK1/2 and p38 MAPK pathway in human promyelocytic leukemia cells. PLoS One 2014;9:e98943.
   PubMed Web of Science ®Google Scholar
• Li X, Zhu F, Jiang JX, et al. Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells. Cancer Lett 2015;357:219–30.
   PubMed Web of Science ®Google Scholar
• Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39–51.
   PubMed Web of Science ®Google Scholar
• Min J, Huang KN, Tang H, et al. Phloretin induces apoptosis of non-small cell lung carcinoma A549 cells via JNK1/2 and p38 MAPK pathways. Oncol Rep 2015;34:2871–9.
   PubMed Web of Science ®Google Scholar
• Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 1998;17:3878–85.
   PubMed Web of Science ®Google Scholar
• Huang Y, Li XH, Wang YR, et al. Endoplasmic reticulum stress-induced hepatic stellate cell apoptosis through calcium-mediated JNK/P38 MAPK and Calpain/Caspase-12 pathways. Mol Cell Biochem 2014;394:1–12.
   PubMed Web of Science ®Google Scholar
• Hao WJ, Yuan X, Yu L, et al. Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways. Sci Rep 2015;5:10336.
   PubMed Web of Science ®Google Scholar
• Ley R, Ewings KE, Hadfield K, et al. Extracellular signal-regulated kinases 1/2 are serum-stimulated “Bim(EL) kinases” that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover. J Biol Chem 2004;279:8837–47.
   PubMed Web of Science ®Google Scholar
• Ewings KE, Hadfield-Moorhouse K, Wiggins CM, et al. ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL. EMBO J 2007;26:2856–67.
   PubMed Web of Science ®Google Scholar
• Kim YK, Kim HJ, Kwon CH, et al. Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J Appl Toxicol 2005;25:374–82.
   PubMed Web of Science ®Google Scholar
• Faris M, Kokot N, Latinis K, et al. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J Immunol 1998;160:134–44.
   PubMed Web of Science ®Google Scholar
• Dhanasekaran DN, Reddy EP. JNK signaling in apoptosis. Oncogene 2008;27:6245–51.
   PubMed Web of Science ®Google Scholar
• Sinha K, Das J, Pal PB, Sil PC. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 2013;87:1157–80.
   PubMed Web of Science ®Google Scholar
• Kang YJ, Zhou ZX, Wang GW, et al. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J Biol Chem 2000;275:13690–8.
   PubMed Web of Science ®Google Scholar